医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BrainChip Earns Australian Patent for Improved Spiking Neural Network
rainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI, received its latest Australian patent, further strengthening its IP portfolio related to sustainable and efficient AI technologies.… 続きを読む
2024年05月07日 AM01:00
2024年05月06日
Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies
iocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG (“BioCopy”), a research-based biotechnology company headquartered in Basel, Switzerland.… 続きを読む
2024年05月06日
New Canva Research Reveals Amid Burnout, Teachers Are Ready to Embrace AI
s the 2023-2024 school year comes to an end, Kindergarten through 12th Grade (K-12) teachers in the US are widely experiencing strain at work: one-third (35%) of U.S. educators reported experiencing burnout on most days, leading to absenteeism and a decline in instructional quality as consequences.… 続きを読む
2024年05月06日
KKR to Acquire Healthium from Apax Funds
KR, a leading global investment firm, today announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium Medtech Ltd. (“Healthium”), a leading Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP (“Apax”), a leading global private equity advisory firm. The acquisition will be made by a special purpose vehicle owned by KKR-managed funds which will acquire a controlling interest in Healthium group, including Healthium.… 続きを読む
2024年05月04日
KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance
CAS Bio continues to deliver against both growth objectives and more integrated customer service offerings. KCAS Bio has partnered with Crux Biolabs, a leading provider of flow cytometry and bioanalytical services located in Melbourne, Australia. KCAS Bio is a leading international Contract Research Organization (CRO) providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and cell/gene therapy industries. KCAS Bio offers a complete range of bioanalytical services from early discovery support through registration, providing expertise in biological (large molecule), synthetic (small molecule), and cell/gene therapy drug candidates. KCAS Bio provides services from its three locations in Kansas City, KS; the greater Philadelphia, PA, region; and Lyon, France.… 続きを読む